Program: Medical
Years: 2026
Grant: $74,670 for 1 year
Organisation: The Walter & Eliza Hall Institute of Medical Research
A novel therapeutic approach for Facioscapulohumeral muscular dystrophy by modulating DNA silencing
Program: Medical
Years: 2026
Grant: $30,673 for 1 year
Organisation: University of Melbourne
Understanding how protein-bacterial interactions in blood impacts macrophage behaviour
Program: Medical
Years: 2026
Grant: $74,413 Year 1 and $73,250 for Year 2
Organisation: University of Melbourne
Uncovering and inhibiting host-cell entry of Human T-cell lymphotropic virus type-1 (HTLV-1)
Program: Medical
Years: 2026
Grant: $70,306 for Year 1 and $70,250 for Year 2
Organisation: The Florey Institute of Neuroscience and Mental Health
Understanding how undergoing open-heart surgery compromises our immune system to develop targeted therapies
Program: Medical
Years: 2026
Grant: $75,000 per year for two years
Organisation: Centre For Eye Research Australia
Closing the Gender Gap: Advancing Diagnosis and Treatment Equity for Women with X-linked Retinal Disease
Program: Medical
Years: 2026
Grant: $75,000 per year for 2 years
Organisation: Hudson Institute of Medical Research
Reducing Respiratory Distress in the Newborn
Program: Medical
Years: 2026
Grant: $73,908 for 1 Year
Organisation: Deakin University
Moving together: How movement behaviours of young children and their parents shape their long-term health
Program: Medical
Years: 2026
Grant: $74,653 for Year 1 and $74,940 for Year 2
Organisation: Swinburne University
SPARC: Stimulating Patient-derived Adipose stem cells for Regenerative Cartilage repair
Program: Medical
Years: 2025
Grant: $75,000 for 1 year
Organisation: St Vincent's Institute of Medical Research
Incorporating a sensory nerve plexus into a bioengineered human skin flap
Program: Medical
Years: 2025
Grant: $75,000 a year for 2 years
Organisation: The MacFarlane Burnet Institute for Medical Research
Enhancing the therapeutic potency of next-generation anti-cancer immunotherapies through stellabody FC engineering.
Program: Medical
Years: 2025
Grant: $75,000 a year for 2 years
Organisation: Centre for Eye Research Australia
Developing a dual-targeting gene therapy to protect the optic nerve in glaucoma.
Program: Medical
Years: 2025
Grant: $73,337 for year 1 and $74,749 for year 2
Organisation: Centre for Eye Research Australia
The role of pericytes in retinal ganglion cell dysfunction and vision loss in glaucoma.